Skip to main content

User account menu

Show — User account menu Hide — User account menu
  • Log in
Home
Amarin

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.

Submitted by amarin on Fri, 09/27/2019 - 21:32
Home
  • Read more about Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.

A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins.

Submitted by amarin on Fri, 09/27/2019 - 21:26
Home
  • Read more about A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins.

Potential benefits of eicosapentaenoic acid on atherosclerotic plaques

Submitted by amarin on Fri, 09/27/2019 - 21:24
Home
  • Read more about Potential benefits of eicosapentaenoic acid on atherosclerotic plaques

Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study

Submitted by amarin on Fri, 09/27/2019 - 21:20
Home
  • Read more about Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study

New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease

Submitted by amarin on Fri, 09/27/2019 - 21:13
Home
  • Read more about New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease

Predicting risk for incident heart failure with omega-3 fatty acids: from MESA.

Submitted by amarin on Fri, 09/27/2019 - 20:55
Home
  • Read more about Predicting risk for incident heart failure with omega-3 fatty acids: from MESA.

Dyslipidemia management in diabetes

Submitted by amarin on Fri, 09/27/2019 - 20:52
Home
  • Read more about Dyslipidemia management in diabetes

The Economic Burden of Hypertriglyceridemia Among US Adults With Diabetes or Atherosclerotic Cardiovascular Disease on Statin Therapy

Submitted by amarin on Fri, 09/27/2019 - 20:41
Home
  • Read more about The Economic Burden of Hypertriglyceridemia Among US Adults With Diabetes or Atherosclerotic Cardiovascular Disease on Statin Therapy

Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A large administrative retrospective analysis.

Submitted by amarin on Fri, 09/27/2019 - 20:37
Home
  • Read more about Hypertriglyceridemia is associated with an increased risk of peripheral arterial revascularization in high-risk statin-treated patients: A large administrative retrospective analysis.

Icosapent ethyl effects on fatty acid profiles in statin-treated patients with high triglycerides: the randomized, placebo-controlled ANCHOR study

Submitted by amarin on Fri, 09/27/2019 - 19:50
Home
  • Read more about Icosapent ethyl effects on fatty acid profiles in statin-treated patients with high triglycerides: the randomized, placebo-controlled ANCHOR study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • Current page 79
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Search

API search

Title (indexed field):
Title (indexed field):
Title (indexed field): Home

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
Powered by Drupal